Amicus Therapeutics IncEigentümerstruktur
| Preis (2026-04-27) | 52W Hoch | 52W Tief |
| 14.49 USD | 14,5 USD | 5,925 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 14,5 USD | 8 | 1 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 314.000.712 | 7,03 | 6,36 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Amicus Therapeutics Inc
Mitarbeiter 511
Handelsplatz NASDAQ
Ticker Symbol FOLD
IPO Datum 2007-05-31
Adresse 47 Hulfish Street, Princeton, NJ, United States, 08542
Webseite https://amicusrx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Bradley L. Campbell M.B.A. | CEO, President & Director |
| 2 | Mr. Simon Nicolas Reade Harford | Chief Financial Officer |
| 3 | Ms. Ellen S. Rosenberg J.D. | Chief Legal Officer & Corporate Secretary |
| 4 | Mr. David M. Clark | Chief People Officer |
| 5 | Dr. Jeffrey P. Castelli Ph.D. | Chief Development Officer |
| 6 | Ms. Samantha L. Prout | Chief Accounting Officer & Controller |
| 7 | Dr. Jill Weimer Ph.D. | Chief Science Officer |
| 8 | Mr. Andrew Faughnan | Vice President of Investor Relations |
| 9 | Mr. Patrik S. Florencio Esq. | Global Chief Compliance & Risk Officer |
| 10 | Mr. Brendan McEvoy | Executive Director of External Communications |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Pentwater Capital Management LP | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 8 | Glazer Capital, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Fidelity International Ltd | 0,00% | 0,00 Mio. USD |
| 10 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 11 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 12 | HBK INVESTMENTS L P | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | O'Connor Alternative Investments, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 17 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 18 | Cnh Partners, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Soros Fund Management LLC | 0,00% | 0,00 Mio. USD |
| 20 | Kryger Capital LLC | 0,00% | 0,00 Mio. USD |